Variable | Symptomatic (n = 6) | Asymptomatic (n = 44) | OR (95% CI) | PValue | AUC |
---|---|---|---|---|---|
Plaque burden | |||||
% wall volume | 61.0 ± 5.8 | 56.1 ± 9.2 | 1.93 (0.70–5.31)a | .204 | 0.689 |
% stenosis on MRA | 50.8 ± 6.9 | 55.5 ± 9.7 | 0.61 (0.25–1.46)a | .265 | 0.339 |
Ulceration on MRA | 50% | 36% | 1.75 (0.32–9.72) | .661 | 0.568 |
Prevalence plaque components | |||||
Fibrous cap thin/ruptured | 100% | 39% | n/a (2.13-infinity)b | .006c | 0.807 |
Lipid-rich necrotic core | 100% | 43% | n/a (1.77-infinity)b | .022c | 0.784 |
Hemorrhage | 67% | 25% | 6.00 (0.96–37.4) | .055 | 0.708 |
Calcifications | 67% | 84% | 0.38 (0.06–2.48) | .311 | 0.413 |
% Volume of plaque components | |||||
Lipid-rich necrotic core | 18.5 ± 12.2 | 6.6 ± 11.3 | 1.90 (1.03–3.51)a | .040 | 0.837 |
Hemorrhage | 6.9 ± 6.6 | 1.9 ± 5.0 | 3.22 (0.97–10.71)a | .056 | 0.750 |
Calcifications | 2.9 ± 3.7 | 4.7 ± 5.9 | 0.44 (0.05–4.02)a | .470 | 0.405 |
a OR and 95% CI for a 10% increase.
b Lower limit CI estimated by exact logistic regression analysis. “n/a” was used because OR cannot be calculated in the presence of zero cells in a 2 × 2 table.
c Fisher exact test.